Dr. Purushottam Kand

Dr. Purushottam Kand
Nuclear Medicine Specialist, Mumbai

MBBS. (Mum), DRM (Mum), DNB (Nuclear Medicine), MNAMS, Diplomate, Certification Board of Nuclear Cardiology (USA), Fellow, European Board of Nuclear Medicine

Dr. Purushottam Kand is a Consultant at the Sir H. N. Reliance Foundation Hospital & Research Centre, offering a wide spectrum of Nuclear Medicine Services - PET CT Imaging, Diagnostic Radionuclide Imaging & Targetted Radionuclide Therapy. 
He has specialized in Thyroid Cancer Care including the diagnosis, evaluation, assesment and planning for various therapies, treatment with follow-up management. 
His expertise also includes the management of other Thyroid disorders, Neuroendocrine Tumours using PRRT and other radionuclide therapies.He also offers OPD based Thyroid Clinic Services.
Previously he was a full time Nuclear Medicine Physician at the Radiation Medicine Centre, the premier Institute for the teaching, training and practice of Nuclear Medicine in India.  
  • Languages :English, Hindi, Marathi

Specialities

  • Nuclear Medicine

Expertise

  • PET-CT Imaging in Oncology.
  • Nuclear Cardiology including myocardial viability assesment using PET Imaging.
  • Therapeutic applications of Nuclear Medicine including Peptide Receptor Radionuclide Therapy.
  • Evaluation and management of Thyroid disorders including Thyroid cancer with special emphasis on Radio-iodine Therapy 
  • Diagnostic Nuclear Medicine

Education

  • MBBS (University of Mumbai)
  • Diploma in Radiation Medicine (University of Mumbai)
  •  Diplomate, National Board of Examinations (Nuclear Medicine)
  • Member National Academy of Medical Sciences
  •   Diplomate Certification Board of Nuclear Cardiology (USA)
  •  Fellowship Examination of the European Board of Nuclear Medicine

Practice Information

Sir H.N. Reliance Foundation Hospital and Research Centre, Mumbai

Sir H.N. Reliance Foundation Hospital and Research Centre, Mumbai

Raja Ram Mohan Roy Road, Prathna Samaj, Girgaum, Mumbai, Maharashtra - 400004

MON - SAT

11:00 AM - 03:00 PM

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Purushottam Kand and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • Increasing cardiac 18F-fluorodeoxyglucose (FDG) uptake on PET–CT as a biomarker for cardiotoxicity of chemo-radiotherapy in cancer: A myth or a reality? Radiotherapy and Oncology 01/2014; DOI: 10.1016/j.radonc.2014.04.019
  • Clinicoradiological characteristics of patients with differentiated thyroid cancer and renal metastasis: case series with follow up. The J Laryng and Otol  (2014), 128, 203–208
  • Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: a pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting. Eur J Nucl Med Mol Imaging. DOI 10.1007/s00259-013-2501-0
  • Myocardial uptake of 18F-fluorodeoxyglucose in whole body positron emission tomography studies. Indian Journal of Nuclear Medicine. Vol 27: Issue 2, April - June 2012: 69-72
  • Enhanced myocardial Fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity? World J Radiol. 2012 May 28;4(5):220-3
  • Impact of FDG-PET and -PET/CT imaging in the clinical decision-making of ovarian carcinoma: an evidence-based approach. Womens Health (Lond Engl). 2012 Mar;8(2):191-203.
  • A pregnant woman with metastatic papillary thyroid carcinoma and paraplegia: Multiple considerations involved in the management. Hell J Nucl Med. 2011 Sep; 14(3):320-1.
  • “Reverse Discordance” between 68Ga-DOTANOC PET/CT and 177Lutetium DOTATATE post-therapy scan: the Plausible Explanations and its Implications for high dose therapy with Radio labeled Somatostatin Analogues. Nucl Med Commun. 2011 Jul; 32(7):654-8.
  • Bilateral renal metastases from papillary thyroid carcinoma on post 131I treatment scan: Flip-flop sign, radioiodine SPET, 18F-FDG PET, CECT and histopathological correlation. Hellenic Journal of Nuclear Medicine. January-April 2011:34-35
  • Are the effects of cannabis dependence on glucose metabolism similar to schizophrenia? An FDG PET understanding. Indian J Psychiatry. 2011 Jan; 53(1):13-20.
  • Metastatic involvement of the spleen in differentiated carcinoma of thyroid. Indian Journal of Nuclear Medicine. Vol 25: Issue 4, October-December 2010: 171-172
  • Exploring the role of FDG-PET in the assessment of bone marrow involvement in patients of lymphoma as interpreted by Qualitative and Semi quantitative Disease Metabolic Activity Parameter. Indian J Cancer. 2010 Oct-Dec;47(4):380-4
  • Cannabis dependence: Effects of cannabis consumption on inter-regional cerebral metabolic relationships in an Indian population. Indian J Psychiatry. 2010 Jul; 52(3):236-42.
  • Micronuclei frequency in peripheral blood lymphocytes of thyroid cancer patients after radioiodine therapy and its relationship with metastasis. Mutation Research 675 (2009) 35–40
  • Broncho-alveolar Carcinoma of Lung Masquerading as Iodine Avid Metastasis in a Patient with Minimally Invasive Follicular Carcinoma of Thyroid. Clinical Nuclear Medicine. 33(1):26-29, January 2008\
  • The Sick Building Syndrome; Indian Journal of Occupational Health, volume 44 no.1 January - March 2001
  • Cataract - A Pilot Study; Bombay Hospital Journal, Volume 44 No.4, October 2002
  • Papers presented at International Conference: Micronuclei Frequency In Non-Metastatic And Metastatic Differentiated Thyroid Carcinoma Patients Receiving Radioiodine Therapy. 10th World Congress in Nuclear Medicine & Biology, 18 – 23 September 2010 at Cape Town, South Africa by the World Federation of Nuclear Medicine & Biology
  • Stratification Based Upon Correlation Between FDG Uptake, MIBI Uptake And Myocardial Contraction As Observed On Myocardial Perfusion Scintigraphy And FDG-PET Study: A Potential Tool For Risk Assessment in Dilated Cardiomyopathy. 10th World Congress in Nuclear Medicine & Biology, 18 – 23 September 2010 at Cape Town, South Africa by the World Federation of Nuclear Medicine & Biology
  • Monitoring Therapy Response with FDG-PET Parameters in Patients of Chronic Myeloid Leukemia – Chronic Phase Receiving Hydroxyurea and Imatinib. 10th World Congress in Nuclear Medicine & Biology, 18 – 23 September 2010 at Cape Town, South Africa by the World Federation of Nuclear Medicine & Biology
  • Myocardial viability assessment in patients with significant LV dysfunction using MPI & FDG-PET. 9th Asia Oceania Congress of Nuclear Medicine & Biology, New Delhi, India in November 2008
  • Study of alteration of glucose metabolism in brain of short term hypothyroid patients using FDG-PET. 9th Asia Oceania Congress of Nuclear Medicine & Biology, New Delhi, India in November 2008
  • Assessing Early Functional Response to Imatinib Therapy in Chronic Myeloid Leukemia Patients using FDG-PET. 9th Asia Oceania Congress of Nuclear Medicine & Biology, New Delhi, India in November 2008
  • Performance of 131 I – MIBG and FDG-PET in assessing neural crest cell tumors: A comparative evaluation in prospective setting. 9th Asia Oceania Congress of Nuclear Medicine & Biology, New Delhi, India in November 2008
  • Assessment of the Regional and Global brain glucose metabolism in the patients with history of alcoholism using 18F-FDG PET scan. 9th Asia Oceania Congress of Nuclear Medicine & Biology, New Delhi, India in November 2008
  • Evaluation of in-vivo cerebral glucose kinetics in short term induced hypothyroidism and Euthyroid state of Differentiated Thyroid Cancer patients using 18 F-FDG PET. 9th Asia Oceania Congress of Nuclear Medicine & Biology, New Delhi, India in November 2008
  • Myocardial uptake of 18F-FDG in whole body PET studies. International conference on Clinical PET and Molecular Nuclear Medicine (IPET 2007).
  • Myocardial glucose kinetics assessment in uncontrolled diabetes mellitus using FDG-PET. 2007 Society of Nuclear Medicine 54th Annual Meeting. June 2 – 6, 2007. Washington, D.C.
  • Study of bone marrow involvement of lymphoma using whole body FDG-PET. B. P. Tiwari, P Kand, N. Nair, S. Gupta. 2007 Society of Nuclear Medicine 54th Annual Meeting. June 2 – 6, 2007. Washington, D.C.
  • Evaluation of in-vivo Myocardial Glucose Kinetics in Uncontrolled Diabetes using FDG-PET. 9th World Congress in Nuclear Medicine & Biology, 22nd – 27th October 2006 at Seoul, Korea by the World Federation of Nuclear Medicine & Biology.
  • Emerging Role for Dual Point FDG-PET Imaging in Suspected Breast Carcinoma. 9th World Congress in Nuclear Medicine & Biology, 22nd – 27th October 2006 at Seoul, Korea by the World Federation of Nuclear Medicine & Biology.
  • Papers presented at National Conference: Delayed imaging of myocardial fluorodeoxyglucose positron emission tomography in patients with CAD. 45th  Annual Conference of the Society of Nuclear Medicine India at Mumbai, India in December 2013.
  • Significance of fludeoxyglucose-positron emission tomography, thyroglobulin suppressibility in patients with elevated thyroglobulin, 131I negative metastatic thyroid carcinoma: Emphasis on group with fludeoxyglucose-positron emission tomography negative disease. 45th  Annual Conference of the Society of Nuclear Medicine India at Mumbai, India in December 2013.
  • Evaluation of micronuclei frequency in peripheral blood lymphocytes of hyperthyroid patients. 45th  Annual Conference of the Society of Nuclear Medicine India at Mumbai, India in December 2013.
  • Effect of high Fat diet on myocardial uptake of FDG. 44th  Annual Conference of the Society of Nuclear Medicine India at Bhubhaneshwar, India in December 2012
  • Retrospective analysis of comparison of 18F-NaF bone PET and MDP bone scan in difficult cases. 43rd  Annual Conference of the Society of Nuclear Medicine India at Chennai, India in December 2011
  • Evaluating the relationship of SUV (max) in the histological proven sites obtained by the FDG-PET scan done at initial diagnosis with the histology and the survival in lymphoma patients. 41st Annual Conference of the Society of Nuclear Medicine India at Jaipur, India in December 2009.
  • Targeted Radiotherapy with Unsealed Sources for Palliation of Painful skeletal metastasis. International Conference on Peaceful uses of Atomic Enengy-2009, New Delhi, India.
  • Role of MPI & FDG-PET in the assessment of viable myocardium in patients with significant LV dysfunction. 38th National Conference of the Society of Nuclear Medicine, India in December 2006 at Jamshedpur, Jharkhand, India.
  • To evaluate the relationship between fasting blood sugar, period of fasting, age of the patient and degree of non-pathological uptake of Fluorodeoxyglucose in myocardium. 38th National Conference of the Society of Nuclear Medicine, India in December 2006 at Jamshedpur, Jharkhand, India.
  • Utility of FDG PET in the detection of bone marrow involvement in malignant lymphoma. 37th National Conference of the Society of Nuclear Medicine, India in December 2005 at Calicut, Kerala, India.